99% Anti Estrogen Steroids Raloxifene Hydrochloride Powder 82640-04-8

99% Purity Anti-estrogen Raloxifene Hydrochloride Powder 82640-04-8

Raloxifene Hydrochloride Alias: Raloxifene HCl; KEOXIFENE; AKOS 92138
Raloxifene Hydrochloride CAS: 82640-04-8
Raloxifene Hydrochloride Purity: 99%
Raloxifene Hydrochloride MF: C28H28ClNO4S
Raloxifene Hydrochloride MW: 510.04
Raloxifene Hydrochloride Appearance: Light yellow powder
Raloxifene Hydrochloride Related Substances: Pharmaceutical Grade
Raloxifene Hydrochloride Storage: Shading, confined preservation
Raloxifene Hydrochloride Manufacturer: SBJ
Raloxifene Hydrochloride Lead time: 1-2 days upon receipt of payment
Raloxifene Hydrochloride Delivery Term: Products below 200Kg by air; Over 200Kg by ship
Raloxifene Hydrochloride Delivery Time: Average 6 days by air; 15 days by ship
Raloxifene Hydrochloride Usage: It is used in the prevention of osteoporosis in postmenopausal women.

May prevent or treat corticosteroid-induced bone loss. American College of Rheumatology states that raloxifene can be offered to select postmenopausal corticosteroid-treated women who refuse hormone replacement therapy or other antiresorptive agents (e. G., bisphosphonates, calcitonin) or in whom such therapies are contraindicated.

Reduction in the incidence of invasive breast cancer in postmenopausal women with osteoporosis.

Reduction in the incidence of invasive breast cancer postmenopausal women at high risk for developing the disease. Effect comparable to that of tamoxifen in reducing the risk of invasive breast cancer (STAR trial). No effect on the risk of lobular carcinoma in situ or ductal carcinoma in situ (STAR trial). Effect on breast cancer incidence in women with BRCA1 or BRCA2 genetic mutations not established.

Not indicated for the treatment of breast cancer or to reduce the risk of recurrence of breast cancer. 1 Not indicated for reduction in the risk of noninvasive breast cancer.

Side effect: Raloxifene may infrequently cause serious blood clots to form in the legs, lungs, or eyes. Other reactions experienced include leg swelling/pain, trouble breathing, chest pain, vision changes. Raloxifene is a teratogenic drug, i. e. can cause developmental abnormalities such as birth defects.

Not indicated for the treatment of breast cancer or to reduce the risk of recurrence of breast cancer. 1 Not indicated for reduction in the risk of noninvasive breast cancer.
Side effect: Raloxifene may infrequently cause serious blood clots to form in the legs, lungs, or eyes. Other reactions experienced include leg swelling/pain, trouble breathing, chest pain, vision changes. Raloxifene is a teratogenic drug, i. e. can cause developmental abnormalities such as birth defects.

- Thank you for interested in our product.
- We are the professional manufacturer over 15 years, good reputation in the globe trade.
- Most of our product are USP standard, and available anytime; good quality and high purity you should enjoy.

- Its important for you to choose a business partner who can offer a competitive price.

1. Pinpoint what you need, specification, CAS No., assay, grade.

2. Ensure the discreet parcel and offer the suitable shipping method for reference.

3. The payment that you available for.

4. Shipped out until you paid 100% in advance.

5. Arrange the shipment according to your requirements.

6. Tracked the code when it is online.